German energy giant EWE AG has cut its Java licensing bill by 60% after migrating from Oracle to Azul Core. The move ...
Azul, the trusted leader in enterprise Java for today’s AI and cloud-first world, today announced that EWE AG, one of Germany ...
With the advent of AI-mediated APIs, the era of manually hard-coding every integration between every microservice may be ...
Microsoft is testing a new Defender for Endpoint capability that will automatically isolate compromised endpoints to thwart attackers' attempts to move laterally across the network. This is now ...
Why does it take a new drug 10 years, on average, to come to market? Part of the reason lies in the dead time in the process. Historically, trials have required tedious tabulations and repeated ...
Built With Spring MVC - The web framework used Gradle - Dependency Management JUnit 4.12 - Testing Framework JaCoCo - Java Code Coverage CodeCov - JaCoCo integration tool for GitHub CircleCI - ...
Endpoints anchor clinical development. They define trial outcomes, determine regulatory approval and shape payer decision making. Traditional endpoints often rely on infrequent, clinic-based ...
The FDA issued draft guidance Jan. 21 proposing the use of minimal residual disease and complete response as primary endpoints to support accelerated approval of drugs for multiple myeloma. The draft ...
Community driven content discussing all aspects of software development from DevOps to design patterns. There are two ways to implement the Java Scanner import: explicitly reference the ...
The FDA's accelerated approval pathway often relies on surrogate endpoints, raising concerns about their predictive value for clinical benefits. Nononcology accelerated approvals from 2013 to 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results